Edition:
United States

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

47.33USD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
$47.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
405,113
52-wk High
$99.45
52-wk Low
$41.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 18.52 -1.535
FY 2017 Dec '17 17.04 2.206
Sep '17 16.81 -1.240
Jun '17 14.62 -3.882
Mar '17 7.05 -1.328
FY 2016 Dec '16 0.08 -1.831
Sep '16 0.00 -1.705
Jun '16 0.00 -3.369
Mar '16 0.00 -2.174
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 23.53 26.00 20.86 44.43
Quarter Ending Sep-18 6 33.39 43.00 30.00 62.30
Year Ending Dec-18 7 121.97 142.00 111.42 261.93
Year Ending Dec-19 9 294.59 388.59 217.82 485.27
Earnings (per share)
Quarter Ending Jun-18 6 -1.77 -1.30 -2.65 -0.83
Quarter Ending Sep-18 6 -1.34 -1.16 -1.62 -0.55
Year Ending Dec-18 7 -5.77 -4.83 -7.28 -2.17
Year Ending Dec-19 9 -3.39 -1.84 -6.75 1.24
LT Growth Rate (%) 1 -92.50 -92.50 -92.50 31.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.89 34.04
P/E High - Last 5 Yrs. -- 290.95 47.73
P/E Low - Last 5 Yrs. -- 100.14 25.07
Beta 1.36 0.73 0.78
Price to Sales (TTM) 38.02 249.29 8.22
Price to Book (MRQ) 7.84 23.95 4.29
Price to Tangible Book (MRQ) 11.57 30.87 6.00
Price to Cash Flow (TTM) -- 143.83 22.60
% Owned Institutions -- 11.87 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.18 -6.32
Payout Ratio(TTM) -- 42.00 40.51

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 162.92 25.06 5.40
Sales (TTM) vs TTM 1 Yr. Ago 840.46 135.46 12.76
Sales - 5 Yr. Growth Rate -- 31.25 7.90
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.66 -86.73 41.23
EPS (TTM) vs TTM 1 Yr. Ago 45.92 -- --
EPS - 5 Yr. Growth Rate -- 49.02 8.05
Capital Spending - 5 Yr. Growth Rate 23.19 36.46 7.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 5.74 1.68 2.55
Current Ratio (MRQ) 6.55 6.34 3.62
LT Debt to Equity (MRQ) 92.32 22.40 13.12
Total Debt to Equity (MRQ) 92.32 26.77 17.61
Interest Coverage (TTM) -28.79 -137.51 36.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 80.46 56.81 55.04
Gross Margin - 5 Yr. Avg. -- 55.33 52.94
EBITD Margin (TTM) -369.75 -- --
EBITD - 5 Yr. Avg -1,515.63 -163.88 15.76
Operating Margin (TTM) -542.77 -890.63 -0.32
Operating Margin - 5 Yr. Avg. -1,928.49 -177.36 10.97
Pre-Tax Margin (TTM) -551.41 -785.00 1.62
Pre-Tax Margin - 5 Yr. Avg. -1,958.11 -180.78 11.14
Net Profit Margin (TTM) -303.67 -778.64 -1.66
Net Profit Margin - 5 Yr. Avg. -1,633.71 -179.59 7.49
Effective Tax Rate (TTM) -- 15.47 29.83
Effective Tax Rate - 5 Yr. Avg. -- 19.38 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 186,081 21,870,457 728,113,809
Net Income/Employee (TTM) -565,075 -128,268 84,561,813
Receivable Turnover (TTM) 8.75 18.25 6.05
Inventory Turnover (TTM) 0.35 2.86 3.66
Asset Turnover (TTM) 0.11 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -33.47 -3.57 10.33
Return on Assets - 5 Yr. Avg. -38.39 -0.69 11.01
Return on Investment (TTM) -37.98 -5.30 13.11
Return on Investment - 5 Yr. Avg. -42.37 2.14 14.30
Return on Equity (TTM) -84.68 -6.83 15.11
Return on Equity - 5 Yr. Avg. -82.11 -2.87 15.65
  1 Year 3 Year 5 Year
Sales % 71,067.95 59.72 --
EPS (TTM) % 56.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clovis Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.41 -0.82 57 78
13 Week -16.34 -18.02 27 43
26 Week -21.29 -23.79 25 88
52 Week -45.34 -51.87 22 90
YTD -28.72 -31.13 21 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 320
Total Shares Held: 53,226,985
3 Mo. Net Change: -1,579,437
# New Positions: 27
# Closed Positions: 53
# Increased Positions: 138
# Reduced Positions: 153
# Net Buyers: -15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.